World Cancer Day: Why Progress in Oncology Depends on Collaboration

Cancer remains one of the greatest medical challenges of our time. World Cancer Day highlights how many people are affected directly or indirectly, and how urgently continued progress in prevention, diagnostics and treatment is needed.

Especially in the life sciences, it becomes clear how important the connection between research, entrepreneurship and targeted support is in bringing new approaches closer to application. Innovation emerges where scientific insight is translated into concrete solutions and where teams are willing to rethink complex medical challenges.

One example is GliTTher, a start-up in the BioIntelligence environment that is developing a personalised therapy for glioblastoma, one of the most aggressive forms of brain cancer. Its approach focuses on addressing the tumour's cause at the cellular level. At the centre are glioma-initiating cells, a cell population strongly associated with glioblastoma recurrence.

World Cancer Day underlines that progress in oncology does not happen in isolation. It depends on excellent research, courageous founders, and an environment that enables long-term innovation.